ALDEYRA THERAPEUTICS, INC. Tax Withholding Paid on Stock Awards
ALDEYRA THERAPEUTICS, INC. (ALDX) reported Tax Withholding Paid on Stock Awards of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2025-02-28
- ALDEYRA THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2024-12-31 was $0.00.
- ALDEYRA THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2023-12-31 was $0.00.
- ALDEYRA THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2022-12-31 was $0.00.
- ALDEYRA THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- ALDEYRA THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $532.95K.
- ALDEYRA THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $0.00.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 10-K · filed 2025-02-28 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $532.95K 10-K · filed 2025-02-28 | |
| 2023-09-30 | $532.95K 10-Q · filed 2024-11-07 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $0.00 10-K · filed 2024-03-07 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |